EP2473170
Notkun Levófloxasíns sem úðaefnis í meðferð við slímseigjukvilla
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.9.2010EP published:
19.6.2019EP application number:
10814595.4
EP translation filed:
1.8.2019Grant published:
15.8.2019EPO information:
European Patent Register
Max expiry date:
2.9.2030Expiry date:
2.9.2026Next due date:
30.9.2026
Title:
USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
Timeline
Today
3.9.2010EP application
19.6.2019EP Publication
1.8.2019Translation submitted
15.8.2019Registration published
2.9.2026Expires
Owner
Name:
Horizon Therapeutics U.S. Holding LLCAddress:
1 Horizon Way, Deerfield, Illinois, 60015, US
Inventor
Name:
LOUTIT, Jefferey, S.Address:
Los AltosCA, US
Name:
MORGAN, Elizabeth, E.Address:
EscondidoCA, US
Name:
DUDLEY, Michael, N.Address:
San DiegoCA, US
Name:
GRIFFITH, David, C.Address:
San MarcosCA, US
Name:
LOMOVSKAYA, OlgaAddress:
CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
249231 PDate:
6.10.2009Country:
US
Number:
240092 PDate:
4.9.2009Country:
US
Classification
Categories:
A61K 31/5383, A61K 33/06, A61K 9/12, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 20.8.2019
Expires: 2.9.2020
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.8.2020
Expires: 2.9.2021
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.8.2021
Expires: 2.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 19.8.2022
Expires: 2.9.2023
Payer: Patice ehf.
Number: 14
Paid: 1.9.2023
Expires: 2.9.2024
Payer: Maxval Group, Inc.
Number: 15
Paid: 23.8.2024
Expires: 2.9.2025
Payer: Maxval Group, Inc.
Number: 16
Paid: 21.8.2025
Expires: 2.9.2026
Payer: Árnason Faktor ehf.